| Retrospective multicenter cohort study shows early interferon therapy is associated with favorable clinical responses in COVID-19 patients N Wang, Y Zhan, L Zhu, Z Hou, F Liu, P Song, F Qiu, X Wang, X Zou, ... Cell host & microbe 28 (3), 455-464. e2, 2020 | 325 | 2020 |
| Position of eukaryotic translation initiation factor eIF1A on the 40S ribosomal subunit mapped by directed hydroxyl radical probing Y Yu, A Marintchev, VG Kolupaeva, A Unbehaun, T Veryasova, SC Lai, ... Nucleic acids research 37 (15), 5167-5182, 2009 | 133 | 2009 |
| Hypoxia-inducible factor-1 drives annexin A2 system-mediated perivascular fibrin clearance in oxygen-induced retinopathy in mice B Huang, AB Deora, KL He, K Chen, G Sui, AT Jacovina, D Almeida, ... Blood, The Journal of the American Society of Hematology 118 (10), 2918-2929, 2011 | 75 | 2011 |
| SARS-CoV-2 immunity and functional recovery of COVID-19 patients 1-year after infection Y Zhan, Y Zhu, S Wang, S Jia, Y Gao, Y Lu, C Zhou, R Liang, D Sun, ... Signal transduction and targeted therapy 6 (1), 368, 2021 | 43 | 2021 |
| Synergistic effects of autophagy/mitophagy inhibitors and magnolol promote apoptosis and antitumor efficacy Y Tang, L Wang, T Yi, J Xu, J Wang, JJ Qin, Q Chen, KM Yip, Y Pan, ... Acta Pharmaceutica Sinica B 11 (12), 3966-3982, 2021 | 39 | 2021 |
| The tumorigenic effect of sphingosine kinase 1 and its potential therapeutic target X Wang, Y Sun, X Peng, SMAS Naqvi, Y Yang, J Zhang, M Chen, Y Chen, ... Cancer Control 27 (1), 1073274820976664, 2020 | 30 | 2020 |
| HEXIM1 controls satellite cell expansion after injury to regulate skeletal muscle regeneration P Hong, K Chen, B Huang, M Liu, M Cui, I Rozenberg, B Chaqour, X Pan, ... The Journal of clinical investigation 122 (11), 3873-3887, 2012 | 14 | 2012 |
| Clinical evidence of an interferon–glucocorticoid therapeutic synergy in COVID-19 Y Lu, F Liu, G Tong, F Qiu, P Song, X Wang, X Zou, D Wan, M Cui, Y Xu, ... Signal Transduction and Targeted Therapy 6 (1), 107, 2021 | 13 | 2021 |
| Viral dynamics during SARS-CoV-2 omicron infection highlight presymptomatic and asymptomatic infectiousness L Jiang, L Tang, L Zhu, Y Zhu, S Yang, W Chen, Y Fan, X Yang, S Yang, ... The Journal of Infection 86 (5), 537, 2022 | 8 | 2022 |
| Association of neutralizing breadth against SARS-CoV-2 with inoculation orders of heterologous prime-boost vaccines Y Zhu, Y Lu, C Zhou, G Tong, M Gao, Y Zhan, Y Wang, R Liang, Y Li, ... Med 3 (8), 568-578. e3, 2022 | 6 | 2022 |
| Omicron-adapted vaccines might require longer follow-up to reveal true benefits L Tang, R Zhang, M Cui, P Hong The Lancet Microbe 4 (1), e12, 2023 | 4 | 2023 |
| Post-recovery enhancement of anti-variant neutralisation after severe COVID-19 Y Lu, Y Zhu, M Cui, Z Cheng, P Hong The Lancet Microbe 3 (5), e330-e331, 2022 | 4 | 2022 |
| Consistent neutralization of circulating omicron sub‐variants by hybrid immunity up to 6 months after booster vaccination AKL Cheung, Y Lu, Y Zhu, TY Fung, Y Zheng, Z Zheng, P Hong Journal of Medical Virology 95 (4), e28694, 2023 | 3 | 2023 |
| Finite neutralisation breadth of omicron after repeated vaccination Y Zhu, Y Lu, L Tang, C Zhou, R Liang, M Cui, Y Xu, Z Zheng, Z Cheng, ... The Lancet Microbe 3 (10), e729, 2022 | 3 | 2022 |
| Nirmatrelvir-ritonavir treatment on SARS-CoV-2 viral dynamics in high altitude habitants A Lu, X Zhou, D Han, L Tang, X Rong, Y Zheng, P Hong The Lancet Regional Health–Western Pacific 30, 2023 | 2 | 2023 |
| Defective induction of regulatory B cells by decidua stromal cells underlies the pathogenesis of preterm birth (P3213) ZY Wang, A Mathiarasu, P Hong, Y Xu, A Li, M Bluth, L Lum, B Huang, ... The Journal of Immunology 190 (1_Supplement), 171.19-171.19, 2013 | 2 | 2013 |
| Humoral immune response to omicron infection in long-term Wuhan-Hu-1-imprinted population Y Lu, Y Zhu, Y Zheng, L Tang, H Chen, C Zhou, J Luo, X Yang, L Yu, Q Hu, ... | 1 | 2023 |
| Persistent vaccine-elicited humoral immune imprinting in Tibetans: a matched cohort study in Tibet Y Zhu, Y Lu, A Lu, C Zhou, P Hong Clinical Microbiology and Infection, 2024 | | 2024 |
| SARS-CoV-2 Nirmatrelvir Resistance—A Concern for Immunocompromised Populations? Z Zhou, P Hong JAMA Network Open 7 (9), e2435439-e2435439, 2024 | | 2024 |
| Recent symptomatic Omicron infection reduced COVID-19 pneumonia risk during reinfection: A computed tomography–based cohort study Y Zheng, S Jia, L Tang, L Yu, X Yang, S Yang, Q Ke, Z Cheng, Y Zhu, ... International Journal of Infectious Diseases 146, 107164, 2024 | | 2024 |
